欢迎来到天天文库
浏览记录
ID:54592390
大小:217.73 KB
页数:3页
时间:2020-05-02
《低分子肝素治疗孕足月病理性高凝状态的效果评价.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、2014年第18卷第5期实用临床医药杂志JournalofClinicalMedicineinPractice·139·低分子肝素治疗孕足月病理性高凝状态的效果评价李书平,陈友国(江苏省常州市第二人民医院产科,江苏常州,213003)摘要:目的探讨低分子肝素治疗孕足月病理性高凝状态的有效性和安全性。方法选取本院分娩D一聚体高于参考值的孕产妇160例并分为治疗组和对照组,每组80例。治疗组予低分子肝素钙4100U皮下注射,1次/d,7d为一个疗程;对照组不予抗凝治疗。同时监测7d低分子肝素应用后、术后/产后2d的
2、凝血功能、D一二聚体值及血常规、妊娠及围产儿结局。结果低分子肝素能明显降低血液高凝状态,能使围生期病理性高凝状态转变为生理性高凝状态,从而降低vTE及DIC的发病率。结论低分子肝素钙能安全有效地预防并治疗孕妇病理性高凝状态,值得临床推广应用。关键词:低分子肝素;孕足月;病理性高凝状态;生理性高凝状态中图分类号:R714.2文献标志码:A文章编号:1672—2353(2014)05-139-03130I:10.7619/3cmp.201405048Effectassessmentoflowmolecularhep
3、arinontreatmentoffull。——termpregnantwomenwithpathologicalhyperc0agulabalestageLIShuping,CHENYouguo(DepartmentofObstetrics,ChangzhouSecondPeopleSHospiml,Changzhou,Jiangsu,213003)ABSTRACT:ObjectiveToexplorethesafetyandefficacyoflowmolecularheparininthetreatmen
4、toffull—termpregnantwomenwithpathologicalhypercoagulabalestage.Methods160pregnantwomenwithoverstandardlevelofD—dimerweredividedintotreatmentgroupandcon—trolgroup.80casesineachgroup.ThetreatmentgroupwastreatedwithlOWmolecularheparincalcium4100Ubysubcutaneousi
5、njectiononceperday,7dayswereconsideredasacourseoftreatment.Thecontrolgroupwasnotconductedwithanticoagulanttherapy.Coagulationfunction,D—dimersandbloodroutine,pregnancyandperinata1outcomeweremonitoredatthetimepointsof7daysafterapplicationoflowmolecularheparin
6、andtwodaysafterspontaneousdeliveryoroper·ation.ResultsLowmolecularheparincouldsignificantlyimprovehematologicalhypercoagulabalestage.anditisabletomaketheperinatalpathologicalhypercoagulabalestagetransfoHntonormalhypercoagulabalestageinordertoreducetheinciden
7、cerateofVTEandDIC.ConclusionLowmolecularheparincanpreventandtreattheperinatalpathologica1hypercoagulabalestageeffectivelyinfull—termpregnantwomen,SOitisworthyofclinicalapplication.KEYWORDS:lOWmolecularheparin;full—termpregnancy;hypercoagulabalestage;physiolo
8、gicalhypercoagulabalestage高凝状态对孕妇、胎儿及新生儿均有可能产比例显著增高,发生率为0.767'00~1.727'00,约为生不良的并发症,其中包括妊娠高血压综合征非孕妇的4倍,是发达国家中母亲死亡的首要致(PIH)、妊娠肝内胆汁淤积综合征(ICP)、弥散性死原因。29%~79%产妇患有血栓形成综合征。血管内凝血(DIC)、胎儿宫内生长发育迟缓(IU—本研究
此文档下载收益归作者所有